Is the New Classification of Neuroendocrine Pancreatic Tumors of Clinical Help? View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2000-11

AUTHORS

Martin Schindl, Klaus Kaczirek, Klaus Kaserer, Bruno Niederle

ABSTRACT

A new concept of classifying neuroendocrine pancreatic tumors based on clinicopathologic patterns was summarized recently. To evaluate the clinical reliability and prognostic specificity of this classification system, 100 neuroendocrine pancreatic tumors were retrospectively categorized as “benign,”“uncertain,” and “malignant” based on tumor risk factors (size, local invasion and angioinvasion, cell atypia, metastases) and were followed for disease recurrence and progression. Altogether, 71 functioning tumors (insulinoma, gastrinoma, glucagonoma, enterochromaffin-like (ECL)oma, somatostatinoma) and 29 nonfunctioning neuroendocrine pancreatic tumors (NETs) were studied. NETs had an increased risk of malignancy (p < 0.05). Tumor size, gross invasion, and metastases correlated significantly with tumor behavior and allowed us to distinguish between “benign” and “malignant” tumors. About 89% of the tumors ≤ 20 mm were “benign,” whereas 71% > 20 mm were “malignant” (p < 0.05). In patients with “benign” and “uncertain” neuroendocrine pancreatic tumors, neither recurrence nor progression of disease was seen. About 41% of the patients with “malignant” tumors died of the disease. The 5-year estimated cumulative survival of those with “benign” and “uncertain” tumors was 100% and 52 ± 10% for those with “malignant” tumors (p < 0.05). Histomorphologic details classifying the behavior of an “uncertain” tumor are known only after initial treatment and definitive histopathologic investigation. Thus this information is of limited clinical help for treatment strategies. More... »

PAGES

1312-1318

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s002680010217

DOI

http://dx.doi.org/10.1007/s002680010217

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1034826001

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/11038199


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biopsy, Needle", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease-Free Survival", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Evaluation Studies as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Staging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neuroendocrine Tumors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pancreatectomy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pancreatic Function Tests", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pancreatic Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Reproducibility of Results", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sensitivity and Specificity", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Rate", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Division of General Surgery, Section of Endocrine Surgery, University of Vienna Medical School, W\u00e4hringer G\u00fcrtel 18-20, A 1090 Vienna, Austria, AT", 
          "id": "http://www.grid.ac/institutes/grid.22937.3d", 
          "name": [
            "Department of Surgery, Division of General Surgery, Section of Endocrine Surgery, University of Vienna Medical School, W\u00e4hringer G\u00fcrtel 18-20, A 1090 Vienna, Austria, AT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schindl", 
        "givenName": "Martin", 
        "id": "sg:person.0603017413.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0603017413.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Division of General Surgery, Section of Endocrine Surgery, University of Vienna Medical School, W\u00e4hringer G\u00fcrtel 18-20, A 1090 Vienna, Austria, AT", 
          "id": "http://www.grid.ac/institutes/grid.22937.3d", 
          "name": [
            "Department of Surgery, Division of General Surgery, Section of Endocrine Surgery, University of Vienna Medical School, W\u00e4hringer G\u00fcrtel 18-20, A 1090 Vienna, Austria, AT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kaczirek", 
        "givenName": "Klaus", 
        "id": "sg:person.01163404744.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01163404744.70"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Clinical Pathology, University of Vienna Medical School, W\u00e4hringer G\u00fcrtel 18-20, A 1090 Vienna, Austria, AT", 
          "id": "http://www.grid.ac/institutes/grid.22937.3d", 
          "name": [
            "Institute of Clinical Pathology, University of Vienna Medical School, W\u00e4hringer G\u00fcrtel 18-20, A 1090 Vienna, Austria, AT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kaserer", 
        "givenName": "Klaus", 
        "id": "sg:person.01046040764.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01046040764.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Division of General Surgery, Section of Endocrine Surgery, University of Vienna Medical School, W\u00e4hringer G\u00fcrtel 18-20, A 1090 Vienna, Austria, AT", 
          "id": "http://www.grid.ac/institutes/grid.22937.3d", 
          "name": [
            "Department of Surgery, Division of General Surgery, Section of Endocrine Surgery, University of Vienna Medical School, W\u00e4hringer G\u00fcrtel 18-20, A 1090 Vienna, Austria, AT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Niederle", 
        "givenName": "Bruno", 
        "id": "sg:person.014465706030.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014465706030.17"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/sj.bjc.6690494", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039860600", 
          "https://doi.org/10.1038/sj.bjc.6690494"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s001090050233", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014446718", 
          "https://doi.org/10.1007/s001090050233"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2000-11", 
    "datePublishedReg": "2000-11-01", 
    "description": "A new concept of classifying neuroendocrine pancreatic tumors based on clinicopathologic patterns was summarized recently. To evaluate the clinical reliability and prognostic specificity of this classification system, 100 neuroendocrine pancreatic tumors were retrospectively categorized as \u201cbenign,\u201d\u201cuncertain,\u201d and \u201cmalignant\u201d based on tumor risk factors (size, local invasion and angioinvasion, cell atypia, metastases) and were followed for disease recurrence and progression. Altogether, 71 functioning tumors (insulinoma, gastrinoma, glucagonoma, enterochromaffin-like (ECL)oma, somatostatinoma) and 29 nonfunctioning neuroendocrine pancreatic tumors (NETs) were studied. NETs had an increased risk of malignancy (p < 0.05). Tumor size, gross invasion, and metastases correlated significantly with tumor behavior and allowed us to distinguish between \u201cbenign\u201d and \u201cmalignant\u201d tumors. About 89% of the tumors \u2264 20 mm were \u201cbenign,\u201d whereas 71% > 20 mm were \u201cmalignant\u201d (p < 0.05). In patients with \u201cbenign\u201d and \u201cuncertain\u201d neuroendocrine pancreatic tumors, neither recurrence nor progression of disease was seen. About 41% of the patients with \u201cmalignant\u201d tumors died of the disease. The 5-year estimated cumulative survival of those with \u201cbenign\u201d and \u201cuncertain\u201d tumors was 100% and 52 \u00b1 10% for those with \u201cmalignant\u201d tumors (p < 0.05). Histomorphologic details classifying the behavior of an \u201cuncertain\u201d tumor are known only after initial treatment and definitive histopathologic investigation. Thus this information is of limited clinical help for treatment strategies.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s002680010217", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1086446", 
        "issn": [
          "0364-2313", 
          "1432-2323"
        ], 
        "name": "World Journal of Surgery", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "11", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "24"
      }
    ], 
    "keywords": [
      "neuroendocrine pancreatic tumors", 
      "pancreatic tumors", 
      "clinical help", 
      "tumor risk factors", 
      "risk of malignancy", 
      "progression of disease", 
      "prognostic specificity", 
      "disease recurrence", 
      "initial treatment", 
      "clinicopathologic patterns", 
      "tumor size", 
      "cumulative survival", 
      "histopathologic investigation", 
      "gross invasion", 
      "risk factors", 
      "treatment strategies", 
      "tumor behavior", 
      "tumors", 
      "clinical reliability", 
      "patients", 
      "recurrence", 
      "disease", 
      "progression", 
      "new classification", 
      "classification system", 
      "histomorphologic detail", 
      "malignancy", 
      "metastasis", 
      "survival", 
      "treatment", 
      "risk", 
      "invasion", 
      "specificity", 
      "factors", 
      "patterns", 
      "strategies", 
      "classification", 
      "investigation", 
      "help", 
      "information", 
      "new concept", 
      "size", 
      "behavior", 
      "reliability", 
      "system", 
      "detail", 
      "concept", 
      "NETs", 
      "definitive histopathologic investigation", 
      "limited clinical help"
    ], 
    "name": "Is the New Classification of Neuroendocrine Pancreatic Tumors of Clinical Help?", 
    "pagination": "1312-1318", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1034826001"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s002680010217"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "11038199"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s002680010217", 
      "https://app.dimensions.ai/details/publication/pub.1034826001"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:10", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_315.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s002680010217"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s002680010217'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s002680010217'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s002680010217'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s002680010217'


 

This table displays all metadata directly associated to this object as RDF triples.

231 TRIPLES      22 PREDICATES      101 URIs      91 LITERALS      29 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s002680010217 schema:about N1d1bc2df5b2d4bcd9005202c0ec23ad9
2 N29b2192598e348199dbb37e5fc8d936d
3 N39ccc4ecf6b24179a73a8a7fefc72b30
4 N534598bfeca74f8c808478bd95c139f6
5 N54a3ebc43a3640fe86b6411dc8eddfd3
6 N54ac6e9f91554730a7932af467b24cef
7 N65fca92814c04ff3bc0b8dbdeceb4e8e
8 N78695c682c9c4e2286c17499d98f422d
9 N88d0d46ce9f9477eb1855afc00eee0b5
10 N8b8fd16695dd42a1b0cad5a82c86f259
11 N923ce420c3084231aa8f6f0c27aa8f81
12 Na8eeaa34215e420c98d416e82f6ba713
13 Nb6dc3fc2bfb7458787e7591af9a4273c
14 Nde75707fbd9f475e8d7c2e6b3369805b
15 Nde991246763b446d9eb26f5914cd974c
16 Ndfa6efce133c4b109269dafd26b9be44
17 Necef9004fe8e41668eaee2cee8b5ebfe
18 Nf0fb9a62e9124d9f87d75de0e0c61b76
19 Nf949762e948943e398e783b6733030e5
20 Nfc960555b9104fd7a9f0c3478bc6b7dd
21 Nfe60c87895d14239b897b7827e2efced
22 Nfedc70c4dc234c0b8f231beea44defeb
23 anzsrc-for:11
24 anzsrc-for:1112
25 schema:author Nd452d595556f46229367983d2cdea5ae
26 schema:citation sg:pub.10.1007/s001090050233
27 sg:pub.10.1038/sj.bjc.6690494
28 schema:datePublished 2000-11
29 schema:datePublishedReg 2000-11-01
30 schema:description A new concept of classifying neuroendocrine pancreatic tumors based on clinicopathologic patterns was summarized recently. To evaluate the clinical reliability and prognostic specificity of this classification system, 100 neuroendocrine pancreatic tumors were retrospectively categorized as “benign,”“uncertain,” and “malignant” based on tumor risk factors (size, local invasion and angioinvasion, cell atypia, metastases) and were followed for disease recurrence and progression. Altogether, 71 functioning tumors (insulinoma, gastrinoma, glucagonoma, enterochromaffin-like (ECL)oma, somatostatinoma) and 29 nonfunctioning neuroendocrine pancreatic tumors (NETs) were studied. NETs had an increased risk of malignancy (p < 0.05). Tumor size, gross invasion, and metastases correlated significantly with tumor behavior and allowed us to distinguish between “benign” and “malignant” tumors. About 89% of the tumors ≤ 20 mm were “benign,” whereas 71% > 20 mm were “malignant” (p < 0.05). In patients with “benign” and “uncertain” neuroendocrine pancreatic tumors, neither recurrence nor progression of disease was seen. About 41% of the patients with “malignant” tumors died of the disease. The 5-year estimated cumulative survival of those with “benign” and “uncertain” tumors was 100% and 52 ± 10% for those with “malignant” tumors (p < 0.05). Histomorphologic details classifying the behavior of an “uncertain” tumor are known only after initial treatment and definitive histopathologic investigation. Thus this information is of limited clinical help for treatment strategies.
31 schema:genre article
32 schema:inLanguage en
33 schema:isAccessibleForFree false
34 schema:isPartOf Nc02e35197fa64df0b139f87c46470f38
35 Nc700a0a574784d2e982bbbcc319bc928
36 sg:journal.1086446
37 schema:keywords NETs
38 behavior
39 classification
40 classification system
41 clinical help
42 clinical reliability
43 clinicopathologic patterns
44 concept
45 cumulative survival
46 definitive histopathologic investigation
47 detail
48 disease
49 disease recurrence
50 factors
51 gross invasion
52 help
53 histomorphologic detail
54 histopathologic investigation
55 information
56 initial treatment
57 invasion
58 investigation
59 limited clinical help
60 malignancy
61 metastasis
62 neuroendocrine pancreatic tumors
63 new classification
64 new concept
65 pancreatic tumors
66 patients
67 patterns
68 prognostic specificity
69 progression
70 progression of disease
71 recurrence
72 reliability
73 risk
74 risk factors
75 risk of malignancy
76 size
77 specificity
78 strategies
79 survival
80 system
81 treatment
82 treatment strategies
83 tumor behavior
84 tumor risk factors
85 tumor size
86 tumors
87 schema:name Is the New Classification of Neuroendocrine Pancreatic Tumors of Clinical Help?
88 schema:pagination 1312-1318
89 schema:productId N74a4c2aa23644f259b530a2aafe80f8d
90 N9d70f942d4a5489aa2cb08522f6f4fe3
91 Nd3f6bf0545be428e83bab590eff3a3d1
92 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034826001
93 https://doi.org/10.1007/s002680010217
94 schema:sdDatePublished 2022-01-01T18:10
95 schema:sdLicense https://scigraph.springernature.com/explorer/license/
96 schema:sdPublisher Nb32db08d820141e19595fea687b5760f
97 schema:url https://doi.org/10.1007/s002680010217
98 sgo:license sg:explorer/license/
99 sgo:sdDataset articles
100 rdf:type schema:ScholarlyArticle
101 N15bfd6b3c9444a8e809e0471d97c814f rdf:first sg:person.01046040764.07
102 rdf:rest Nde38207ada0743fc9f50f259541b98bf
103 N1d1bc2df5b2d4bcd9005202c0ec23ad9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Evaluation Studies as Topic
105 rdf:type schema:DefinedTerm
106 N29b2192598e348199dbb37e5fc8d936d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Reproducibility of Results
108 rdf:type schema:DefinedTerm
109 N39ccc4ecf6b24179a73a8a7fefc72b30 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Adolescent
111 rdf:type schema:DefinedTerm
112 N534598bfeca74f8c808478bd95c139f6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Neoplasm Staging
114 rdf:type schema:DefinedTerm
115 N54a3ebc43a3640fe86b6411dc8eddfd3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Female
117 rdf:type schema:DefinedTerm
118 N54ac6e9f91554730a7932af467b24cef schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Sensitivity and Specificity
120 rdf:type schema:DefinedTerm
121 N65fca92814c04ff3bc0b8dbdeceb4e8e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Humans
123 rdf:type schema:DefinedTerm
124 N74a4c2aa23644f259b530a2aafe80f8d schema:name pubmed_id
125 schema:value 11038199
126 rdf:type schema:PropertyValue
127 N78695c682c9c4e2286c17499d98f422d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Retrospective Studies
129 rdf:type schema:DefinedTerm
130 N88d0d46ce9f9477eb1855afc00eee0b5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Male
132 rdf:type schema:DefinedTerm
133 N8b8fd16695dd42a1b0cad5a82c86f259 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Child
135 rdf:type schema:DefinedTerm
136 N923ce420c3084231aa8f6f0c27aa8f81 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Aged, 80 and over
138 rdf:type schema:DefinedTerm
139 N9d70f942d4a5489aa2cb08522f6f4fe3 schema:name dimensions_id
140 schema:value pub.1034826001
141 rdf:type schema:PropertyValue
142 Na8eeaa34215e420c98d416e82f6ba713 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Follow-Up Studies
144 rdf:type schema:DefinedTerm
145 Nb32db08d820141e19595fea687b5760f schema:name Springer Nature - SN SciGraph project
146 rdf:type schema:Organization
147 Nb6dc3fc2bfb7458787e7591af9a4273c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Survival Rate
149 rdf:type schema:DefinedTerm
150 Nc02e35197fa64df0b139f87c46470f38 schema:volumeNumber 24
151 rdf:type schema:PublicationVolume
152 Nc3a83bf59d68406f8ee4ebb771478b71 rdf:first sg:person.01163404744.70
153 rdf:rest N15bfd6b3c9444a8e809e0471d97c814f
154 Nc700a0a574784d2e982bbbcc319bc928 schema:issueNumber 11
155 rdf:type schema:PublicationIssue
156 Nd3f6bf0545be428e83bab590eff3a3d1 schema:name doi
157 schema:value 10.1007/s002680010217
158 rdf:type schema:PropertyValue
159 Nd452d595556f46229367983d2cdea5ae rdf:first sg:person.0603017413.32
160 rdf:rest Nc3a83bf59d68406f8ee4ebb771478b71
161 Nde38207ada0743fc9f50f259541b98bf rdf:first sg:person.014465706030.17
162 rdf:rest rdf:nil
163 Nde75707fbd9f475e8d7c2e6b3369805b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Pancreatic Function Tests
165 rdf:type schema:DefinedTerm
166 Nde991246763b446d9eb26f5914cd974c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Disease-Free Survival
168 rdf:type schema:DefinedTerm
169 Ndfa6efce133c4b109269dafd26b9be44 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Aged
171 rdf:type schema:DefinedTerm
172 Necef9004fe8e41668eaee2cee8b5ebfe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Neuroendocrine Tumors
174 rdf:type schema:DefinedTerm
175 Nf0fb9a62e9124d9f87d75de0e0c61b76 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Pancreatectomy
177 rdf:type schema:DefinedTerm
178 Nf949762e948943e398e783b6733030e5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Biopsy, Needle
180 rdf:type schema:DefinedTerm
181 Nfc960555b9104fd7a9f0c3478bc6b7dd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Middle Aged
183 rdf:type schema:DefinedTerm
184 Nfe60c87895d14239b897b7827e2efced schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
185 schema:name Adult
186 rdf:type schema:DefinedTerm
187 Nfedc70c4dc234c0b8f231beea44defeb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
188 schema:name Pancreatic Neoplasms
189 rdf:type schema:DefinedTerm
190 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
191 schema:name Medical and Health Sciences
192 rdf:type schema:DefinedTerm
193 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
194 schema:name Oncology and Carcinogenesis
195 rdf:type schema:DefinedTerm
196 sg:journal.1086446 schema:issn 0364-2313
197 1432-2323
198 schema:name World Journal of Surgery
199 schema:publisher Springer Nature
200 rdf:type schema:Periodical
201 sg:person.01046040764.07 schema:affiliation grid-institutes:grid.22937.3d
202 schema:familyName Kaserer
203 schema:givenName Klaus
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01046040764.07
205 rdf:type schema:Person
206 sg:person.01163404744.70 schema:affiliation grid-institutes:grid.22937.3d
207 schema:familyName Kaczirek
208 schema:givenName Klaus
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01163404744.70
210 rdf:type schema:Person
211 sg:person.014465706030.17 schema:affiliation grid-institutes:grid.22937.3d
212 schema:familyName Niederle
213 schema:givenName Bruno
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014465706030.17
215 rdf:type schema:Person
216 sg:person.0603017413.32 schema:affiliation grid-institutes:grid.22937.3d
217 schema:familyName Schindl
218 schema:givenName Martin
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0603017413.32
220 rdf:type schema:Person
221 sg:pub.10.1007/s001090050233 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014446718
222 https://doi.org/10.1007/s001090050233
223 rdf:type schema:CreativeWork
224 sg:pub.10.1038/sj.bjc.6690494 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039860600
225 https://doi.org/10.1038/sj.bjc.6690494
226 rdf:type schema:CreativeWork
227 grid-institutes:grid.22937.3d schema:alternateName Department of Surgery, Division of General Surgery, Section of Endocrine Surgery, University of Vienna Medical School, Währinger Gürtel 18-20, A 1090 Vienna, Austria, AT
228 Institute of Clinical Pathology, University of Vienna Medical School, Währinger Gürtel 18-20, A 1090 Vienna, Austria, AT
229 schema:name Department of Surgery, Division of General Surgery, Section of Endocrine Surgery, University of Vienna Medical School, Währinger Gürtel 18-20, A 1090 Vienna, Austria, AT
230 Institute of Clinical Pathology, University of Vienna Medical School, Währinger Gürtel 18-20, A 1090 Vienna, Austria, AT
231 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...